Journal of Clinical Endocrinology & Metabolism, Vol 74, 313-321, Copyright © 1992 by Endocrine Society

ARTICLES

Cortisol receptor resistance: the variability of its clinical presentation and response to treatment

SW Lamberts, JW Koper, P Biemond, FH den Holder and FH de Jong
Department of Medicine, Erasmus University, Rotterdam, The Netherlands.

Primary (partial) cortisol receptor resistance was previously reported in a total of 7 patients and 14 asymptomatic family members. Its occurrence is considered to be extremely rare. In the present study we report on 6 patients (2 males and 4 females) with the syndrome. The first male patient presented with mild hypertension. Hydrochlorothiazide therapy resulted in life-threatening hypokalemia. The second male patient had slight hypertension without hypokalemia. All four female patients presented between the age of 20-30 yr with acne, hirsutism, and irregular menstruations. Low dose dexamethasone therapy (1-1.5 mg/day) was of clinical benefit in these patients. All patients showed insufficient suppression of serum cortisol concentrations in the overnight 1-mg dexamethasone test. The diurnal rhythm of ACTH and cortisol was intact, albeit at an elevated level. There was a normal increase in ACTH, cortisol, and GH (except in one obese patient) in response to insulin-induced hypoglycemia, while cortisol production was elevated in three patients. Circulating adrenal androgen levels were increased in all patients. Glucocorticoid receptors were investigated in a whole cell dexamethasone binding assay in mononuclear leukocytes. In the first male patient, the number of receptors was very low, while the affinity was lower than that in controls. A lowered affinity to dexamethasone was found in one female patient, while a lowered number of receptors was found in three patients. In the second male patient, no abnormalities were found. As a bioassay for glucocorticoid action we also measured dexamethasone suppressibility of mitogen-stimulated incorporation of [3H]thymidine in mononuclear leukocytes. In the male patient with normal receptor status, dexamethasone suppressibility of [3H]thymidine incorporation was significantly lower than that in healthy controls with respect to both maximal suppression and IC50. Partial cortisol receptor resistance might be less rare than previously thought. In the six patients presented, at least three different forms can be recognized. Therapy with dexamethasone was successful in female patients with acne and hirsutism, as the secondary increase in the production of adrenal androgens was effectively controlled.

This article has been cited by other articles:

				H. Russcher, P. Smit, E. F. C. van Rossum, E. L. T. van den Akker, A. O. Brinkmann, L. J. M. de Heide, F. H. de Jong, J. W. Koper, and S. W. J. Lamberts Strategies for the Characterization of Disorders in Cortisol Sensitivity J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 694 - 701. [Abstract] [Full Text] [PDF]

				P. Smit, H. Russcher, F. H. de Jong, A. O. Brinkmann, S. W. J. Lamberts, and J. W. Koper Differential Regulation of Synthetic Glucocorticoids on Gene Expression Levels of Glucocorticoid-Induced Leucine Zipper and Interleukin-2 J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2994 - 3000. [Abstract] [Full Text] [PDF]

				E R. DE KLOET and R. DERIJK Signaling Pathways in Brain Involved in Predisposition and Pathogenesis of Stress-Related Disease: Genetic and Kinetic Factors Affecting the MR/GR Balance Ann. N.Y. Acad. Sci., December 1, 2004; 1032(1): 14 - 34. [Abstract] [Full Text] [PDF]

				G U. MEDURI and C. R. YATES Systemic Inflammation-Associated Glucocorticoid Resistance and Outcome of ARDS Ann. N.Y. Acad. Sci., June 1, 2004; 1024(1): 24 - 53. [Abstract] [Full Text] [PDF]

				E. F.C. van Rossum and S. W.J. Lamberts Polymorphisms in the Glucocorticoid Receptor Gene and Their Associations with Metabolic Parameters and Body Composition Recent Prog. Horm. Res., January 1, 2004; 59(1): 333 - 357. [Abstract] [Full Text]

				G.U. Meduri, P. Carratu, and A.X. Freire Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS Eur. Respir. J., August 1, 2003; 22(42_suppl): 57s - 64s. [Abstract] [Full Text] [PDF]

				E. F.C. van Rossum, J. W. Koper, N. A.T.M. Huizenga, A. G. Uitterlinden, J. A.M.J.L. Janssen, A. O. Brinkmann, D. E. Grobbee, F. H. de Jong, C. M. van Duyn, H. A.P. Pols, et al. A Polymorphism in the Glucocorticoid Receptor Gene, Which Decreases Sensitivity to Glucocorticoids In Vivo, Is Associated With Low Insulin and Cholesterol Levels Diabetes, October 1, 2002; 51(10): 3128 - 3134. [Abstract] [Full Text] [PDF]

				T. KINO, A. VOTTERO, E. CHARMANDARI, and G. P. CHROUSOS Familial/Sporadic Glucocorticoid Resistance Syndrome and Hypertension Ann. N.Y. Acad. Sci., September 1, 2002; 970(1): 101 - 111. [Abstract] [Full Text] [PDF]

				G T Verhoeven, J P J J Hegmans, P G H Mulder, J M Bogaard, H C Hoogsteden, and J-B Prins Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness Thorax, August 1, 2002; 57(8): 694 - 700. [Abstract] [Full Text] [PDF]

				B. Marchetti, M. C. Morale, J. Brouwer, C. Tirolo, N. Testa, S. Caniglia, N. Barden, S. Amor, P. A. Smith, and C. D. Dijkstra Exposure to a Dysfunctional Glucocorticoid Receptor from Early Embryonic Life Programs the Resistance to Experimental Autoimmune Encephalomyelitis Via Nitric Oxide-Induced Immunosuppression J. Immunol., June 1, 2002; 168(11): 5848 - 5859. [Abstract] [Full Text] [PDF]

				G. U. Meduri, E. A. Tolley, G. P. Chrousos, and F. Stentz Prolonged Methylprednisolone Treatment Suppresses Systemic Inflammation in Patients with Unresolving Acute Respiratory Distress Syndrome . Evidence for Inadequate Endogenous Glucocorticoid Secretion and Inflammation-induced Immune Cell Resistance to Glucocorticoids Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 983 - 991. [Abstract] [Full Text] [PDF]

				T. Kino, R. H. Stauber, J. H. Resau, G. N. Pavlakis, and G. P. Chrousos Pathologic Human GR Mutant Has a Transdominant Negative Effect on the Wild-Type GR by Inhibiting Its Translocation into the Nucleus: Importance of the Ligand-Binding Domain for Intracellular GR Trafficking J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5600 - 5608. [Abstract] [Full Text] [PDF]

				A Stevens, D W Ray, J Worthington, and J R. Davis Polymorphisms of the human prolactin gene--implications for production of lymphocyte prolactin and systemic lupus erythematosus Lupus, October 1, 2001; 10(10): 676 - 683. [Abstract] [PDF]

				W Shamim, M Yousufuddin, D P Francis, P Gualdiero, J W Honour, S D Anker, and A J S Coats Raised urinary glucocorticoid and adrenal androgen precursors in the urine of young hypertensive patients: possible evidence for partial glucocorticoid resistance Heart, August 1, 2001; 86(2): 139 - 144. [Abstract] [Full Text] [PDF]

				T.M. O'CONNOR, D.J. O'HALLORAN, and F. SHANAHAN The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia QJM, June 1, 2000; 93(6): 323 - 333. [Abstract] [Full Text] [PDF]

				N. A. T. M. Huizenga, P. de Lange, J. W. Koper, W. W. de Herder, R. Abs, J. H. L. M. v. Kasteren, F. H. de Jong, and S. W. J. Lamberts Five Patients with Biochemical and/or Clinical Generalized Glucocorticoid Resistance without Alterations in the Glucocorticoid Receptor Gene J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2076 - 2081. [Abstract] [Full Text]

				Adrenal Hyperandrogenism in Children J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4431 - 4435. [Full Text]

				R. A. Ramos, W. J. Meilandt, E. C. Wang, and G. L. Firestone Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant FASEB J, January 1, 1999; 13(1): 169 - 180. [Abstract] [Full Text]

				E. R. de Kloet, E. Vreugdenhil, M. S. Oitzl, and M. Joëls Brain Corticosteroid Receptor Balance in Health and Disease Endocr. Rev., June 1, 1998; 19(3): 269 - 301. [Abstract] [Full Text]

				M. Panarelli, C. D. Holloway, R. Fraser, J. M. C. Connell, M. C. Ingram, N. H. Anderson, and C. J. Kenyon Glucocorticoid Receptor Polymorphism, Skin Vasoconstriction, and Other Metabolic Intermediate Phenotypes in Normal Human Subjects J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1846 - 1852. [Abstract] [Full Text]

				I. Dijkstra, F. J. H. Tilders, G. Aguilera, A. Kiss, C. Rabadan-Diehl, N. Barden, S. Karanth, F. Holsboer, and J. M. H. M. Reul Reduced Activity of Hypothalamic Corticotropin-Releasing Hormone Neurons in Transgenic Mice with Impaired Glucocorticoid Receptor Function J. Neurosci., May 15, 1998; 18(10): 3909 - 3918. [Abstract] [Full Text] [PDF]

				N. A. T. M. Huizenga, P. de Lange, J. W. Koper, R. N. Clayton, W. E. Farrell, A. J. van der Lely, A. O. Brinkmann, F. H. de Jong, and S. W. J. Lamberts Human Adrenocorticotropin-Secreting Pituitary Adenomas Show Frequent Loss of Heterozygosity at the Glucocorticoid Receptor Gene Locus J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 917 - 921. [Abstract] [Full Text]

				N. A. T. M. Huizenga, J. W. Koper, P. de Lange, H. A. P. Pols, R. P. Stolk, H. Burger, D. E. Grobbee, A. O. Brinkmann, F. H. de Jong, and S. W. J. Lamberts A Polymorphism in the Glucocorticoid Receptor Gene May Be Associated with an Increased Sensitivity to Glucocorticoids in Vivo J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 144 - 151. [Abstract] [Full Text]

				P. Mulatero, M. Panarelli, D. Schiavone, A. Rossi, G. Mengozzi, C. J. Kenyon, L. Chiandussi, and F. Veglio Impaired Cortisol Binding to Glucocorticoid Receptors in Hypertensive Patients Hypertension, November 1, 1997; 30(5): 1274 - 1278. [Abstract] [Full Text]

				P. de Lange, J. W. Koper, N. A. T. M. Huizenga, A. O. Brinkmann, F. H. de Jong, M. Karl, G. P. Chrousos, and S. W. J. Lamberts Differential Hormone-Dependent Transcriptional Activation and -Repression by Naturally Occurring Human Glucocorticoid Receptor Variants Mol. Endocrinol., July 1, 1997; 11(8): 1156 - 1164. [Abstract] [Full Text]